Sulindac sodium

This classification denotes a cyclooxygenase inhibitor C20H16FO3S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NJV14I2XPC, chemically known as 1h-indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, sodium salt (1:1), (1z)-, but more generally known as sulindac sodium, which bears US NIH Compound Identifier 23676448. European Medicines Agency schedules Sulindac sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04640MIG. Most nations, for tariff and trade purposes, schedule sulindac sodium under HS 29309085 and SITC 51549. As of Q4 2014, SULINDAC SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CC\1=C(C2CC(CCC2/C1=C\C3CCC(CC3)[S+](C)[O-])F)CC(=O)[O-].[NA+].